tradingkey.logo

AxoGen Inc

AXGN

17.260USD

+0.440+2.62%
收盘 09/18, 16:00美东报价延迟15分钟
789.91M总市值
亏损市盈率 TTM

AxoGen Inc

17.260

+0.440+2.62%
关于 AxoGen Inc 公司
Axogen, Inc. 专注于周围神经再生和修复技术的科学、开发和商业化。该公司为外科医生和医疗保健提供者提供修复解决方案。其产品包括 Avance 神经移植物、Axoguard 神经连接器、Axoguard 神经保护器、Axoguard 神经帽、Axotouch 双点鉴别器和 Axoguard HA+ 神经保护器。Avance 神经移植物是一种生物活性处理的人类神经同种异体移植物,用于桥接断裂的周围神经,而不会产生与第二个手术部位相关的并发症。Axoguard 神经连接器是一种猪粘膜下层细胞外基质接合辅助剂,用于无张力修复断裂的周围神经。Axoguard 神经保护器是一种猪粘膜下层 ECM 产品,用于包裹和保护受损的周围神经并加强神经重建,同时防止软组织附着。Axotouch 双点鉴别器用于测量皮肤任何表面积的神经支配密度。
公司简介
公司代码AXGN
公司名称AxoGen Inc
上市日期Dec 17, 1986
CEOMr. Michael Donald (Mike) Dale
员工数量451
证券类型Ordinary Share
年结日Dec 17
公司地址13631 Progress Blvd.
城市ALACHUA
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编32615
电话13864626817
网址https://www.axogeninc.com/
公司代码AXGN
上市日期Dec 17, 1986
CEOMr. Michael Donald (Mike) Dale
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Erick Wayne Devinney
Mr. Erick Wayne Devinney
Chief Innovation Officer
Chief Innovation Officer
151.77K
+0.91%
Mr. Paul G. Thomas
Mr. Paul G. Thomas
Independent Chairman of the Board
Independent Chairman of the Board
21.40K
-38.73%
Ms. Lindsey Hartley
Ms. Lindsey Hartley
Chief Financial Officer
Chief Financial Officer
20.76K
--
Mr. Jens Schroeder Kemp
Mr. Jens Schroeder Kemp
Chief Marketing Officer
Chief Marketing Officer
12.68K
-54.18%
Mr. Rick Ditto
Mr. Rick Ditto
Vice President - Global Health Economics, Reimbursement & Policy
Vice President - Global Health Economics, Reimbursement & Policy
--
--
Mr. John H. Johnson
Mr. John H. Johnson
Independent Director
Independent Director
--
--
Ms. Kathy Weiler
Ms. Kathy Weiler
Independent Director
Independent Director
--
--
Mr. Marc A. Began
Mr. Marc A. Began
Executive Vice President, Chief Compliance Officer, General Counsel
Executive Vice President, Chief Compliance Officer, General Counsel
--
--
Mr. William P. (Bill) Burke
Mr. William P. (Bill) Burke
Independent Director
Independent Director
--
--
Mr. Alan M. Levine
Mr. Alan M. Levine
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Erick Wayne Devinney
Mr. Erick Wayne Devinney
Chief Innovation Officer
Chief Innovation Officer
151.77K
+0.91%
Mr. Paul G. Thomas
Mr. Paul G. Thomas
Independent Chairman of the Board
Independent Chairman of the Board
21.40K
-38.73%
Ms. Lindsey Hartley
Ms. Lindsey Hartley
Chief Financial Officer
Chief Financial Officer
20.76K
--
Mr. Jens Schroeder Kemp
Mr. Jens Schroeder Kemp
Chief Marketing Officer
Chief Marketing Officer
12.68K
-54.18%
Mr. Rick Ditto
Mr. Rick Ditto
Vice President - Global Health Economics, Reimbursement & Policy
Vice President - Global Health Economics, Reimbursement & Policy
--
--
Mr. John H. Johnson
Mr. John H. Johnson
Independent Director
Independent Director
--
--
收入明细
FY2023
FY2022
暂无数据
地区USD
名称
营收
占比
United States
159.01M
0.00%
业务
地区
暂无数据
股东统计
更新时间: 8月16日 周六
更新时间: 8月16日 周六
持股股东
股东类型
持股股东
持股股东
占比
First Light Asset Management, LLC
9.84%
BlackRock Institutional Trust Company, N.A.
6.74%
The Vanguard Group, Inc.
5.92%
Morgan Stanley & Co. LLC
4.20%
Balyasny Asset Management LP
4.20%
其他
69.10%
持股股东
持股股东
占比
First Light Asset Management, LLC
9.84%
BlackRock Institutional Trust Company, N.A.
6.74%
The Vanguard Group, Inc.
5.92%
Morgan Stanley & Co. LLC
4.20%
Balyasny Asset Management LP
4.20%
其他
69.10%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
36.08%
Investment Advisor
26.43%
Hedge Fund
18.12%
Research Firm
5.98%
Individual Investor
4.69%
Bank and Trust
0.34%
Pension Fund
0.30%
Sovereign Wealth Fund
0.13%
Insurance Company
0.03%
其他
7.90%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
352
41.91M
91.08%
-2.35M
2025Q1
357
42.08M
92.45%
-1.70M
2024Q4
343
39.00M
87.97%
-5.62M
2024Q3
323
39.49M
90.05%
-1.54M
2024Q2
302
38.53M
87.94%
-4.16M
2024Q1
307
37.61M
87.02%
-4.05M
2023Q4
318
35.68M
82.81%
-5.15M
2023Q3
322
35.50M
82.64%
-5.39M
2023Q2
319
36.28M
84.47%
-3.01M
2023Q1
324
35.99M
84.11%
-3.05M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
First Light Asset Management, LLC
4.47M
9.82%
-32.58K
-0.72%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.13M
6.87%
+93.19K
+3.07%
Mar 31, 2025
The Vanguard Group, Inc.
2.53M
5.55%
+103.94K
+4.28%
Mar 31, 2025
Morgan Stanley & Co. LLC
1.59M
3.48%
-105.62K
-6.24%
Mar 31, 2025
Balyasny Asset Management LP
680.19K
1.49%
+380.25K
+126.77%
Mar 31, 2025
ArrowMark Colorado Holdings, LLC
1.59M
3.49%
-657.69K
-29.25%
Mar 31, 2025
Soleus Capital Management, L.P.
1.45M
3.18%
-1.51M
-51.08%
Mar 31, 2025
Wasatch Global Investors Inc
774.63K
1.7%
+774.63K
--
Mar 31, 2025
Zaderej (Karen L)
1.14M
2.51%
+71.04K
+6.62%
Mar 21, 2024
State Street Global Advisors (US)
1.01M
2.23%
+49.10K
+5.08%
Mar 31, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
KeyAI